Mink Therapeutics Inc

Biotech Stocks Healthcare Stocks

$10.57

+0.04 (+0.38%)

As of Apr 1, 10:09 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 7 88%

Hold 1 13%

Sell 0 0%

Price Target

Analyst Price Target +88.9% upside

Low Target $17.96

Average Target $19.97

High Target $26.10

Current Price $10.57

Current
$10.57

Target
$19.97

$17.96 $19.97 avg $26.10

Scenario Analysis

Bear Case

$17.96

69.9%

Low target

Base Case

$19.97

+88.9%

Avg target

Bull Case

$26.10

+146.9%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$76.00

-86.1% from high

52-Week Low

$6.34

+66.7% from low

Target vs 52W High

$19.97

-73.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%